TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  Benzinga

Deadline Soon: MoonLake Immunotherapeutics (MLTX) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit

Benzinga Logo Benzinga By Business Wire
Deadline Soon: MoonLake Immunotherapeutics (MLTX) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit

Law firm alerts investors about a potential securities fraud class action lawsuit against MoonLake Immunotherapeutics after disappointing Phase 3 drug trial results caused significant stock price decline.

Insights
MLTX   negative

Stock dropped 89.9% after revealing Phase 3 trial failure for lead drug candidate sonelokimab, with allegations of misleading investors about the drug's potential advantages